heart disease

Novo Nordisk’s (NYSE:NVO) (OTC:NONOF) obesity medication, Wegovy, has been shown to cause more weight loss in women with prevalent heart disease than in men with the same condition. What Happened: In a recent analysis of study data, involving 1,145 patients, centered on a condition known as...

By Franca Quarneti via El Planteo According to a study by the Canadian Medical Association Journal, adults under the age of 45 who used cannabis in the 30 days prior to the research suffered nearly twice as many heart attacks as those who did not use marijuana. Regardless of the mode of consumption...

Today, Cytokinetics Incorporated (NASDAQ: CYTK) reported positive REDWOOD-HCM Phase 2 data showing CK-274 treatment for ten weeks resulted in substantial and statistically significant reductions in the average resting left ventricular outflow tract pressure gradient (LVOT-G) and...

Cytokinetics Incorporated (NASDAQ: CYTK) has announced positive topline results from Cohorts 1 and 2 of REDWOOD-HCM Phase 2 trial of CK-3773274 (CK-274) in hypertrophic cardiomyopathy (HCM).  The Company plans to initiate Phase 3 trial by the end of 2021. Results demonstrated...

The plot deepens regarding the biotech company Amarin (NASDAQ: AMRN) and its controversial cholesterol-controlling drug, Vascepa. As previously reported on Benzinga, Amarin was waiting to hear the results of a Food and Drug Administration ruling. The company had appealed the FDA's October...